Zoledronic acid injection is a bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis,Treatment to increase bone mass in men with osteoporosis,Treatment and prevention of glucocorticoid-induced osteoporosis,Treatment of Paget’s disease of bone in men and women.
From the U.S. FDA-approved label for Zoledronic acid. Full label: DailyMed.
Zoledronic acid injection is a bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis,Treatment to increase bone mass in men with osteoporosis,Treatment and prevention of glucocorticoid-induced osteoporosis,Treatment of Paget’s disease of bone in men and women.
From the U.S. FDA-approved label for Zoledronic acid. Full label: DailyMed.
Infusion given intravenously over no less than 15 minutes: Treatment of postmenopausal osteoporosis; treatment to increase bone mass in men with osteoporosis: treatment and prevention of glucocorticoid-induced osteoporosis: 5 mg once a year Prevention of postmenopausal osteoporosis: 5 mg once every 2 years Treatment of Paget’s disease of bone: a single 5 mg infusion.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Zoledronic acid injection is contraindicated in patients with the following conditions: Hypocalcemia, Creatinine clearance less than 35 mL/min and in those with evidence of acute renal impairment due to an increased risk of renal failure., Known hypersensitivity to zoledronic acid or any components of zoledronic acid injection. Hypersensitivity reactions including urticaria, angioedema, and anaphylactic reaction/shock have been reported.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Products Containing Same Active Ingredient: Patients receiving Zometa should not receive zoledronic acid injection Hypocalcemia may worsen during treatment. Patients must be adequately supplemented with calcium and vitamin D Renal Impairment: A single dose should not exceed 5 mg and the duration of infusion should be no less than 15 minutes. Renal toxicity may be greater in patients with underlying renal impairment or with other risk factors, including advanced age or dehydration. Monitor creatinine clearance before each dose Osteonecrosis of the Jaw (ONJ) has been reported.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The most common adverse reactions (greater than 10%) were pyrexia, myalgia, headache, arthralgia, pain in extremity. Other important adverse reactions were flu-like illness, nausea, vomiting, diarrhea, and eye inflammation. To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
47 products from 39 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Aclasta 5mg/100ml Infusion | Zoledronic acid (5mg/100ml) | Novartis India Ltd | bottle of 100 ml Infusion |
| Alzic 4mg Injection | Zoledronic acid (4mg) | Adley Formulations | vial of 1 Injection |
| Bdolenic 4mg Injection | Zoledronic acid (4mg) | BDR Pharmaceuticals Internationals Pvt | vial of 1 Injection |
| Blaztere 4mg Injection | Zoledronic acid (4mg) | Dr Reddy's Laboratories Ltd | vial of 1 Injection |
| Cezol 4mg Injection | Zoledronic acid (4mg) | Health Biotech Limited | vial of 1 Injection |
| Dronicad 4mg Injection | Zoledronic acid (4mg) | Cadila Pharmaceuticals Ltd | vial of 1 Injection |
| Gemdronic 5mg/100ml Injection | Zoledronic acid (5mg/100ml) | Alkem Laboratories Ltd | bottle of 100 ml Infusion |
| Ledronzol 4mg Injection | Zoledronic acid (4mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Mabfro 4mg Injection | Zoledronic acid (4mg) | Taj Pharma India Ltd | vial of 1 Powder for Injection |
| Natzold Infusion | Zoledronic acid (5mg/100ml) | Natco Pharma Ltd | vial of 100 ml Infusion |
| Newbona Infusion | Zoledronic acid (5mg/100ml) | Akumentis Healthcare Ltd | bottle of 100 ml Infusion |
| Osteomet Injection | Zoledronic acid (4mg) | Neon Laboratories Ltd | packet of 1 Injection |
| Rokfos Solution for Infusion | Zoledronic acid (5mg/100ml) | Cipla Ltd | bottle of 100 ml Solution for Infusion |
| Sibazol 4mg Injection | Zoledronic acid (4mg) | Siba Lifesciences | vial of 1 Injection |
| Xolnic Injection | Zoledronic acid (4mg) | Khandelwal Laboratories Pvt Ltd | vial of 1 Injection |
| Zifonate 4mg Injection | Zoledronic acid (4mg) | Miracalus Pharma Pvt Ltd | vial of 1 Powder for Injection |
| Zimanex 4mg Injection | Zoledronic acid (4mg) | Metta Life Sciences Private Limited | vial of 1 Injection |
| Zobilan Injection | Zoledronic acid (4mg) | Mylan Pharmaceuticals Pvt Ltd | vial of 5 ml Solution for Infusion |
| Zobone 4mg Injection | Zoledronic acid (4mg) | Sun Pharmaceutical Industries Ltd | vial of 1 ml Injection |
| Zobone 5mg/100ml Infusion | Zoledronic acid (5mg/100ml) | Sun Pharmaceutical Industries Ltd | bottle of 100 ml Infusion |
| Zodnic Infusion | Zoledronic acid (5mg/100ml) | H & I Critical Care | bottle of 100 ml Infusion |
| Zolasta 4mg Injection | Zoledronic acid (4mg) | Intas Pharmaceuticals Ltd | vial of 10 ml Injection |
| Zoldonat 4mg Injection | Zoledronic acid (4mg) | Natco Pharma Ltd | vial of 1 Injection |
| Zoldro 4mg Injection | Zoledronic acid (4mg) | United Biotech Pvt Ltd | vial of 1 Injection |
| Zoldron Injection | Zoledronic acid (4mg) | Getwell Pharmaceutical Pvt Ltd | vial of 1 Injection |
| Zolecare 4mg Injection | Zoledronic acid (4mg) | Medicare Remedies Pvt Ltd | vial of 1 Injection |
| Zoled 4mg Injection | Zoledronic acid (4mg) | Symbion Lifescience | vial of 1 Injection |
| Zoledac 4mg Powder for Injection | Zoledronic acid (4mg) | Aureate Healthcare Pvt Ltd | vial of 1 Powder for Injection |
| Zoledron 4mg Injection | Zoledronic acid (4mg) | Shantha Biotech | vial of 1 Injection |
| Zoleget Injection | Zoledronic acid (4mg) | GLS Pharma Ltd. | vial of 1 Injection |
Showing 30 of 47 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Store at 25°C (77°F);
Storage information from the U.S. FDA-approved label.
Zoledronic acid is recorded in the NepalDoc medicine catalog for: Hypercalcaemia of malignancy, Bone malignancies, Paget's disease of bone, Postmenopausal osteoporosis.
For Hypercalcaemia of malignancy: Ibandronic acid.
For Paget's disease of bone: Alendronate (alendronic acid).
For Postmenopausal osteoporosis: Calcium + Vitamin d3, Nandrolone.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.